Dena Mohamadzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dena Mohamadzadeh has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Shirin Assar
Clinical Research Development Center, Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran
12 shared publications Mehdi Salimi
Clinical Research Development Center, Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran
4 shared publicationsMehran Pournazari
Clinical Research Development Center Imam Reza Hospital, Kermanshah University of Medical Sciences Kermanshah Iran
4 shared publications- Mehran Pournazari
Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah
4 shared publications - Faraneh Farsad
Department of Adult Rheumatology, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications - Parviz Soufivand
Rheumatology Department, Clinical Research Development Center, Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran
3 shared publications
Latest Publications
- Open Access
- 24 July 2025
- Published by PAGEPress Publications in Reumatismo
- Vol. 77 (4)
Factors associated with life quality, sleep quality, and depression in systemic sclerosis patients: a cross-sectional study from Iran
Objective. This study aimed to determine the prevalence and associated factors of depressive symptoms, poor sleep, and life quality among patients with systemic sclerosis (SSc). Methods. This was a cross-sectional study including 120 SSc patients. Demographic and clinical data were obtained. The Short Form Health Survey 36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), and short form of the Beck Depression Questionnaire were used to evaluate life quality, sleep quality, and self-reported depressive symptoms, respectively. The obtained data were analyzed to identify the demographic and clinical risk associations for depressive symptoms, poor sleep, and life quality. Results. Of 120 participants, 108 patients (90%) were female. The mean age was 42.23 years, and the mean disease duration was 13.58 years. Most of the patients were married, unemployed, or housekeepers. Most of them had moderate economic conditions and tertiary education. The total scores of the SF-36 and PSQI questionnaires were 93.25±3.7 and 9.02±4.51, respectively, which showed good life quality but poor sleep quality. The prevalence of depressive symptoms was 44.16% (n=53), and most of them had mild to moderate depressive symptoms. The factors that correlated with life quality were occupational status and cough. The factors that negatively correlated with sleep quality were the presence of digital ulcers, cough, and dysphasia. The presence of cough, dyspnea, and gastroesophageal reflux disease was associated with depressive symptoms. Conclusions. Our study showed a high prevalence of poor sleep quality and depressive symptoms among SSc patients. We found that gastrointestinal symptoms, respiratory symptoms, and digital ulcers affected patients’ life quality, sleep quality, and mental status. Our results also demonstrated that depression was correlated with poor sleep quality, and they were both risk factors for diminished life quality. Identification of these factors would help to make pharmacological and non-pharmacological interventions to improve the quality of life and sleep in SSc patients.
- 24 July 2025
- Published by PAGEPress Publications in Reumatismo
- Vol. 77 (4)
Open AccessFactors associated with life quality, sleep quality, and depression in systemic sclerosis patients: a cross-sectional study from Iran
Objective. This study aimed to determine the prevalence and associated factors of depressive symptoms, poor sleep, and life quality among patients with systemic sclerosis (SSc). Methods. This was a cross-sectional study including 120 SSc patients. Demographic and clinical data were obtained. The Short Form Health Survey 36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), and short form of the Beck Depression Questionnaire were used to evaluate life quality, sleep quality, and self-reported depressive symptoms, respectively. The obtained data were analyzed to identify the demographic and clinical risk associations for depressive symptoms, poor sleep, and life quality. Results. Of 120 participants, 108 patients (90%) were female. The mean age was 42.23 years, and the mean disease duration was 13.58 years. Most of the patients were married, unemployed, or housekeepers. Most of them had moderate economic conditions and tertiary education. The total scores of the SF-36 and PSQI questionnaires were 93.25±3.7 and 9.02±4.51, respectively, which showed good life quality but poor sleep quality. The prevalence of depressive symptoms was 44.16% (n=53), and most of them had mild to moderate depressive symptoms. The factors that correlated with life quality were occupational status and cough. The factors that negatively correlated with sleep quality were the presence of digital ulcers, cough, and dysphasia. The presence of cough, dyspnea, and gastroesophageal reflux disease was associated with depressive symptoms. Conclusions. Our study showed a high prevalence of poor sleep quality and depressive symptoms among SSc patients. We found that gastrointestinal symptoms, respiratory symptoms, and digital ulcers affected patients’ life quality, sleep quality, and mental status. Our results also demonstrated that depression was correlated with poor sleep quality, and they were both risk factors for diminished life quality. Identification of these factors would help to make pharmacological and non-pharmacological interventions to improve the quality of life and sleep in SSc patients.
- Open Access
- 19 December 2023
- Published by PAGEPress Publications in Reumatismo
- Vol. 75 (4) , 196-201
Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review
Acquired hemophilia A (AHA) is a rare autoimmune disorder with unpredictable hemostasis that is caused by autoantibody formation against coagulation factor VIII. AHA can occur in the context of autoimmune inflammatory rheumatic disorders. Here we report the case of a 62-year-old female with an 11-year history of rheumatoid arthritis (RA) who presented with cutaneous and mucosal bleeding. Activated partial thromboplastin time was prolonged and not corrected by the mixing test. Factor VIII activity was decreased, and the anti-factor VIII antibody was positive. AHA associated with RA was diagnosed. The patient was treated with rituximab 500 mg weekly for 4 doses and prednisolone 10 mg/daily. The patient did not experience bleeding events after treatment, and factor VIII activity and inhibitor normalized. At the end of the article, we discuss similar cases of RA-associated AHA.
- 19 December 2023
- Published by PAGEPress Publications in Reumatismo
- Vol. 75 (4) , 196-201
Open AccessAcquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review
Acquired hemophilia A (AHA) is a rare autoimmune disorder with unpredictable hemostasis that is caused by autoantibody formation against coagulation factor VIII. AHA can occur in the context of autoimmune inflammatory rheumatic disorders. Here we report the case of a 62-year-old female with an 11-year history of rheumatoid arthritis (RA) who presented with cutaneous and mucosal bleeding. Activated partial thromboplastin time was prolonged and not corrected by the mixing test. Factor VIII activity was decreased, and the anti-factor VIII antibody was positive. AHA associated with RA was diagnosed. The patient was treated with rituximab 500 mg weekly for 4 doses and prednisolone 10 mg/daily. The patient did not experience bleeding events after treatment, and factor VIII activity and inhibitor normalized. At the end of the article, we discuss similar cases of RA-associated AHA.
- Open Access
- 13 July 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (7) , e7703
Granulomatosis with polyangiitis with salivary glands involvement: Presenting a case and describing its clinical, pathophysiological, and therapeutic aspects
Key Clinical Message: Granulomatosis with polyangiitis (GPA), a rare form of small vessel vasculitis, may be manifested by multisystem involvement misleading its definitive diagnosis. The involvement of salivary glands is a very rare characteristic of GPA. Herein, we described a case of GPA with submandibular salivary gland involvement followed by reviewing the literature on similar cases. The case was a 31‐year‐old man, a known case of seronegative peripheral arthritis that referred recently with bilateral enlargement of the parotid and submandibular glands. Pulmonary nodules were also evident in the patient's CT scan. Fine‐needle aspiration under ultrasound guidance indicated the presence of degenerated squamoid cells, giant cells, and inflammatory cells with a priority of neutrophils in the submandibular gland, as well as the presence of a cyst containing fluid without the evidence of malignancy in the parotid gland. The positivity for the Anti‐neutrophil Cytoplasmic Antibody (C‐ANCA) marker was also revealed. The patient was treated with methotrexate, prednisolone, and rituximab which led to a gradual reduction in the size of the glands and the improvement of the patient's clinical symptoms within 1 month after the treatment. Enlargement of salivary glands in the context of inflammatory disorders can raise doubts about the existence of GPA, and therefore imaging evaluation and histopathological assessment with an ANCA test will be necessary to confirm or rule out it.
- 13 July 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (7) , e7703
Open AccessGranulomatosis with polyangiitis with salivary glands involvement: Presenting a case and describing its clinical, pathophysiological, and therapeutic aspects
Key Clinical Message: Granulomatosis with polyangiitis (GPA), a rare form of small vessel vasculitis, may be manifested by multisystem involvement misleading its definitive diagnosis. The involvement of salivary glands is a very rare characteristic of GPA. Herein, we described a case of GPA with submandibular salivary gland involvement followed by reviewing the literature on similar cases. The case was a 31‐year‐old man, a known case of seronegative peripheral arthritis that referred recently with bilateral enlargement of the parotid and submandibular glands. Pulmonary nodules were also evident in the patient's CT scan. Fine‐needle aspiration under ultrasound guidance indicated the presence of degenerated squamoid cells, giant cells, and inflammatory cells with a priority of neutrophils in the submandibular gland, as well as the presence of a cyst containing fluid without the evidence of malignancy in the parotid gland. The positivity for the Anti‐neutrophil Cytoplasmic Antibody (C‐ANCA) marker was also revealed. The patient was treated with methotrexate, prednisolone, and rituximab which led to a gradual reduction in the size of the glands and the improvement of the patient's clinical symptoms within 1 month after the treatment. Enlargement of salivary glands in the context of inflammatory disorders can raise doubts about the existence of GPA, and therefore imaging evaluation and histopathological assessment with an ANCA test will be necessary to confirm or rule out it.
- Open Access
- 7 June 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (6) , e7473
Bilateral acute anterior uveitis and optic nerve edema as a manifestation of coronavirus disease‐2019 (COVID‐19): A case report
Key clinical message: Acute anterior uveitis and optic disk edema could be a manifestation of COVID‐19 infection, and healthcare providers should be aware of this possible consequence for in‐time diagnosis and treatment. Since the beginning of the coronavirus disease‐2019 (COVID‐19) pandemic, a wide range of clinical manifestations have been associated with this novel infection. The objective of this study was to show that acute anterior uveitis and optic disk edema could be possible manifestations of COVID‐19 infection. The patient was a nine‐year‐old girl presenting with prolonged fever, myalgia, cough, diarrhea, and skin rashes. She also reported blurred vision, Photophobia, and eye redness. PCR test for COVID‐19 returned positive. Imaging investigations showed pleural and pericardial effusion, mediastinal lymphadenopathy, and heart valve regurgitation. She was diagnosed with MIS‐C and treated with methylprednisolone and IVIG. Bilateral acute anterior uveitis and optic disk edema was detected by slit lamp and fundus examination. She was successfully treated and follow‐up ophthalmologic examinations showed improvement.
- 7 June 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (6) , e7473
Open AccessBilateral acute anterior uveitis and optic nerve edema as a manifestation of coronavirus disease‐2019 (COVID‐19): A case report
Key clinical message: Acute anterior uveitis and optic disk edema could be a manifestation of COVID‐19 infection, and healthcare providers should be aware of this possible consequence for in‐time diagnosis and treatment. Since the beginning of the coronavirus disease‐2019 (COVID‐19) pandemic, a wide range of clinical manifestations have been associated with this novel infection. The objective of this study was to show that acute anterior uveitis and optic disk edema could be possible manifestations of COVID‐19 infection. The patient was a nine‐year‐old girl presenting with prolonged fever, myalgia, cough, diarrhea, and skin rashes. She also reported blurred vision, Photophobia, and eye redness. PCR test for COVID‐19 returned positive. Imaging investigations showed pleural and pericardial effusion, mediastinal lymphadenopathy, and heart valve regurgitation. She was diagnosed with MIS‐C and treated with methylprednisolone and IVIG. Bilateral acute anterior uveitis and optic disk edema was detected by slit lamp and fundus examination. She was successfully treated and follow‐up ophthalmologic examinations showed improvement.
- Open Access
- 22 May 2023
- Published by Wiley
Blue-gray discoloration of the skin after levofloxacin exposure in a 44-year-old man with pulmonary tuberculosis
IntroductionHuman tuberculosis (TB) is primarily caused by Mycobacterium tuberculosis. Pulmonary disease occurs in 70-90% of the patients being the most commonly affected sites. The standard therapeutic regimen for TB as recommended by World Health Organization (WHO), consists of two months of the intensive phase, and four months of the continuation phase. The intensive-phase drugs include isoniazid (H) 5 mg/kg, rifampin (R) 10 mg/kg, ethambutol (E) 15 mg/kg, and pyrazinamide (Z) 25 mg/kg. Then isoniazid and rifampin are continued for the next four months. In the cases of resistance to isoniazid, treatment with a combination of rifampin, ethambutol, pyrazinamide, and a quinolone antibiotic such as levofloxacin (Lfx) is performed for a total of six months [1-3]. Drug-induced hepatitis is the most well-known complication of anti-TB treatment. Other adverse events include anorexia, vomiting, abdominal pain, peripheral neuropathy, thrombocytopenia, renal reactions, and skin rashes [4]. Here, we reported a rare complication of levofloxacin which was used as a second-line agent for TB treatment.
- 22 May 2023
- Published by Wiley
Open AccessBlue-gray discoloration of the skin after levofloxacin exposure in a 44-year-old man with pulmonary tuberculosis
IntroductionHuman tuberculosis (TB) is primarily caused by Mycobacterium tuberculosis. Pulmonary disease occurs in 70-90% of the patients being the most commonly affected sites. The standard therapeutic regimen for TB as recommended by World Health Organization (WHO), consists of two months of the intensive phase, and four months of the continuation phase. The intensive-phase drugs include isoniazid (H) 5 mg/kg, rifampin (R) 10 mg/kg, ethambutol (E) 15 mg/kg, and pyrazinamide (Z) 25 mg/kg. Then isoniazid and rifampin are continued for the next four months. In the cases of resistance to isoniazid, treatment with a combination of rifampin, ethambutol, pyrazinamide, and a quinolone antibiotic such as levofloxacin (Lfx) is performed for a total of six months [1-3]. Drug-induced hepatitis is the most well-known complication of anti-TB treatment. Other adverse events include anorexia, vomiting, abdominal pain, peripheral neuropathy, thrombocytopenia, renal reactions, and skin rashes [4]. Here, we reported a rare complication of levofloxacin which was used as a second-line agent for TB treatment.
- Open Access
- 8 May 2023
- Published by PAGEPress Publications in Reumatismo
- Vol. 75 (1) , 35-43
Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran
The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the rheumatology outpatient clinic of Kermanshah university of medical sciences. In this cross-sectional study, RA patients were asked to complete the Morisky questionnaire and 19-item compliance questionnaire for rheumatology (CQR). Patients were divided into two groups: adherent and non-adherent to treatment, based on the CQR questionnaire results. Demographic and clinical characteristics (age, sex, marital status, education level, economical condition, occupational status, place of residence, underlying diseases, type, and number of drugs) were compared between the two groups to investigate possible risk associations for poor adherence. 257 patients completed the questionnaires (mean age: 43.22, 80.2% female). 78.6% were married, 54.9% were housekeepers, 37.7% had tertiary education, 61.9% had moderate economic status, and 73.2% were residents of an urban area with a large population. Prednisolone was the most commonly used drug followed by non-steroidal anti-inflammatory drugs, sulfasalazine, hydroxychloroquine, and methotrexate. The mean score of the Morisky questionnaire was 5.528 (standard deviation=1.79). 105 patients (40.9%) were adherent to treatment based on the CQR questionnaire. High education level (college or university) was correlated with non-adherence to treatment [27 (25.71%) vs 70 (46.05%), p=0.004]. We concluded that the prevalence of non-adherence to treatment is 59.1% in rheumatoid arthritis patients in Kermanshah, Iran. Having a higher education level is a risk factor for poor treatment adherence. Other variables could not predict treatment adherence.
- 8 May 2023
- Published by PAGEPress Publications in Reumatismo
- Vol. 75 (1) , 35-43
Open AccessAdherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran
The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the rheumatology outpatient clinic of Kermanshah university of medical sciences. In this cross-sectional study, RA patients were asked to complete the Morisky questionnaire and 19-item compliance questionnaire for rheumatology (CQR). Patients were divided into two groups: adherent and non-adherent to treatment, based on the CQR questionnaire results. Demographic and clinical characteristics (age, sex, marital status, education level, economical condition, occupational status, place of residence, underlying diseases, type, and number of drugs) were compared between the two groups to investigate possible risk associations for poor adherence. 257 patients completed the questionnaires (mean age: 43.22, 80.2% female). 78.6% were married, 54.9% were housekeepers, 37.7% had tertiary education, 61.9% had moderate economic status, and 73.2% were residents of an urban area with a large population. Prednisolone was the most commonly used drug followed by non-steroidal anti-inflammatory drugs, sulfasalazine, hydroxychloroquine, and methotrexate. The mean score of the Morisky questionnaire was 5.528 (standard deviation=1.79). 105 patients (40.9%) were adherent to treatment based on the CQR questionnaire. High education level (college or university) was correlated with non-adherence to treatment [27 (25.71%) vs 70 (46.05%), p=0.004]. We concluded that the prevalence of non-adherence to treatment is 59.1% in rheumatoid arthritis patients in Kermanshah, Iran. Having a higher education level is a risk factor for poor treatment adherence. Other variables could not predict treatment adherence.
- Open Access
- 26 April 2023
- Published by Wiley
Bilateral acute anterior uveitis and optic nerve edema as a manifestation of coronavirus disease-2019 (COVID-19): a case report
Introduction: Coronavirus disease-2019 (COVID-19) is a novel infection, that first appeared in Wuhan, China. It has been well established that different organs including the heart, kidney, pulmonary and gastrointestinal systems might be involved during or post COVID-19 infection. A possible reason is that the virus enters host cells through the angiotensin-converting enzyme 2 (ACE 2) receptor and this receptor is expressed by different human organs [1]. ACE 2 receptor is also expressed in different parts of the eyes including the conjunctiva, cornea, limbus, aqueous humor, and retina [2].In addition, COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) can affect different organ systems including skin, renal, cardiac, hematological, and gastrointestinal systems. But ocular involvement is not still a part of the world health organization (WHO) criteria or the Center for Disease Control and Prevention criteria for MIS-C [3].Whether uveitis or optic disk edema would be manifestations of acute COVID-19 infection or they can occur as a part of COVID-19-associated MIS-C is still unknown.
- 26 April 2023
- Published by Wiley
Open AccessBilateral acute anterior uveitis and optic nerve edema as a manifestation of coronavirus disease-2019 (COVID-19): a case report
Introduction: Coronavirus disease-2019 (COVID-19) is a novel infection, that first appeared in Wuhan, China. It has been well established that different organs including the heart, kidney, pulmonary and gastrointestinal systems might be involved during or post COVID-19 infection. A possible reason is that the virus enters host cells through the angiotensin-converting enzyme 2 (ACE 2) receptor and this receptor is expressed by different human organs [1]. ACE 2 receptor is also expressed in different parts of the eyes including the conjunctiva, cornea, limbus, aqueous humor, and retina [2].In addition, COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) can affect different organ systems including skin, renal, cardiac, hematological, and gastrointestinal systems. But ocular involvement is not still a part of the world health organization (WHO) criteria or the Center for Disease Control and Prevention criteria for MIS-C [3].Whether uveitis or optic disk edema would be manifestations of acute COVID-19 infection or they can occur as a part of COVID-19-associated MIS-C is still unknown.
- Open Access
- 22 April 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (4) , e7238
Cutaneous vasculitis after COVID‐19 vaccination in a 41‐year‐old male
Leukocytoclastic vasculitis could be a possible adverse event of different SARS‐CoV‐2 vaccines. Clinicians and manufacturers should be aware of this adverse event for appropriate diagnosis and treatment.
- 22 April 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (4) , e7238
Open AccessCutaneous vasculitis after COVID‐19 vaccination in a 41‐year‐old male
Leukocytoclastic vasculitis could be a possible adverse event of different SARS‐CoV‐2 vaccines. Clinicians and manufacturers should be aware of this adverse event for appropriate diagnosis and treatment.
- Open Access
- 12 April 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (4) , e7194
Acute respiratory distress syndrome after spontaneous rupture of a large pulmonary hydatid cyst in a 17‐year‐old male: A case report
Pulmonary hydatid cysts (PHC) and their complications are still a health concern in endemic countries. Here we described a 17‐year‐old male presented with a large PHC with a spontaneous rupture. He developed acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. He was treated with albendazole, broad‐spectrum antibiotics, and corticosteroids. The patient's general condition did not allow any attempt for surgical resection of the cyst. He was discharged in stable condition after one month and referred to a thoracic surgeon for resection of the cyst. As far as we know ARDS after hydatid cyst rupture was rarely reported, and through this case report we aimed to raise awareness of this possible life‐threatening complication.
- 12 April 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (4) , e7194
Open AccessAcute respiratory distress syndrome after spontaneous rupture of a large pulmonary hydatid cyst in a 17‐year‐old male: A case report
Pulmonary hydatid cysts (PHC) and their complications are still a health concern in endemic countries. Here we described a 17‐year‐old male presented with a large PHC with a spontaneous rupture. He developed acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. He was treated with albendazole, broad‐spectrum antibiotics, and corticosteroids. The patient's general condition did not allow any attempt for surgical resection of the cyst. He was discharged in stable condition after one month and referred to a thoracic surgeon for resection of the cyst. As far as we know ARDS after hydatid cyst rupture was rarely reported, and through this case report we aimed to raise awareness of this possible life‐threatening complication.
- Open Access
- 4 March 2023
- Published by Wiley
Cutaneous vasculitis after COVID-19 vaccination in a 41-year-old male
Cutaneous vasculitis after COVID-19 vaccination in a 41-year-old maleMehran Pournazari1, Shirin Assar1, Faraneh Farsad2, Dena Mohamadzadeh11Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran2 Research Centre of Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 4 March 2023
- Published by Wiley
Open AccessCutaneous vasculitis after COVID-19 vaccination in a 41-year-old male
Cutaneous vasculitis after COVID-19 vaccination in a 41-year-old maleMehran Pournazari1, Shirin Assar1, Faraneh Farsad2, Dena Mohamadzadeh11Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran2 Research Centre of Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran